Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Hu, Alan Yung Chih ^a   Tseng, Yu Fen ^a   Weng, Tsai Chuan ^a   Liao, Chien Chun ^a   Wu, Johnson ^a   Chou, Ai Hsiang ^a   Chao, Hsin Ju ^a   Gu, Anna ^a   Chen, Janice ^a   Lin, Su Chen ^a   Hsiao, Chia Hsin ^a   Wu, Suh Chin ^a,b   Chong, Pele ^a,c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; FORMALDEHYDE; INACTIVATED VACCINE; INFLUENZA VACCINE; VIRUS ANTIGEN; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; BIOREACTOR; CELL GROWTH; CELL STRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DRUG CONTAMINATION; DRUG DOSE COMPARISON; DRUG MANUFACTURE; DRUG MEGADOSE; DRUG SYNTHESIS; FEMALE; IMMUNOGENICITY; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; LOW DRUG DOSE; NONHUMAN; SCALE UP; SEROCONVERSION; VIRUS NEUTRALIZATION; ANIMAL; AVIAN INFLUENZA; BIOSYNTHESIS; BIRD; CELL LINE; CELL PROLIFERATION; CULTURE TECHNIQUE; DOG; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; PANDEMIC;

ANIMALIA; ORTHOMYXOVIRIDAE;

ANIMALS; BIOREACTORS; BIRDS; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; DOGS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; PANDEMICS; VACCINES, INACTIVATED;

EID: 79551531033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014578     Document Type: Article

References (29)

1. World Health Organisations (2011) Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO 5 January 2011.
2. Tree JA, Richardson C, Fooks AR, Clegg JC, Looby D (2001) Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 19: 3444-3450.
3. Genzel Y, Behrendt I, König S, Sann H, Reichl U (2004) Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 22: 2202-2208.
4. Hu AY-C, Weng T-C, Tseng Y-F, Chen Y-S, Wu C-H, et al. (2008) Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Vaccine 26: 5736-5740.
5. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, et al. (1998) Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16: 960-968.
6. Wood JM, Oxford JS, Dunleavy U, Newman RW, Major D, et al. (1989) Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology 171: 214-221.
7. Nerome K, Kumihashi H, Nerome R, Hiromoto Y, Yokota Y, et al. (1999) Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model. Developments in Biological Standardization 98: 53-63.
8. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, et al. (1999) A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production. Wien Klin Wochenschr 111: 207-214.
9. Wright PF (2008) Vaccine Preparedness - Are We Ready for the Next Influenza Pandemic? N Engl J Med 358: 2540-2543.
10. Kistner O, Howard MK, Spruth M, Wodal W, Brühl P, et al. (2007) Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. Vaccine 25: 6028-6036.
11. Merten OW (2000) Safety for vaccine(e)s. Cytotechnology 34: 181-183.
12. Croughan MS, Hamel J-F, Wang DIC (2000) Hydrodynamic effects on animal cells grown in microcarrier cultures. Biotechnology and Bioengineering 67: 841-852.
13. van der Pol L, Tramper J (1998) Shear sensitivity of animal cells from a culturemedium perspective. Trends in Biotechnology 16: 323-328.
14. Butler M, Burgener A, Patrick M, Berry M, Moffatt D, et al. (2000) Application of a serum-free medium for the growth of Vero cells and the production of reovirus. Biotechnol Progress 16: 854-858.
15. Toriniwa H, Komiya T (2007) Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor. Biologicals 35: 221-226.
16. Genzel Y, Olmer RM, Schäfer B, Reichl U (2006) Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serumfree media. Vaccine 24: 6074-6087.
17. Rourou S, van der Ark A, van der Velden T, Kallel H (2007) A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine 25: 3879-3889.
18. Merten OW, Kallel H, Manuguerra JC, Tardy-Panit M, Crainic R, et al. (1999) The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses. Cytotechnology 30: 191-201.
19. Frazatti-Gallina NM, Mourão-Fuches RM, Paoli RL, Silva MLN, Miyaki C, et al. (2004) Vero-cell rabies vaccine produced using serum-free medium. Vaccine 23: 511-517.
20. Genzel Y, Fischer M, Reichl U (2006) Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine 24: 3261-3272.
21. Wood JM, Schild GC, Newman RW, Seagroatt V (1977) An improved single radial immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. Journal of Biological Standardization 5: 237-247.
22. Liu J, Shi X, Schwartz R, Kemble G (2009) Use of MDCK cells for production of live attenuated influenza vaccine. Vaccine 27: 6460-6463.
23. Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, et al. (2009) Current challenges in implementing cell-derived influenza vaccines: Implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. Vaccine 27: 2907-2913.
24. Fishbein DB, Yenne KM, Dreesen DW, Teplis CF, Mehta N, et al. (1993) Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationawide prospective study. Vaccine 11: 1390-1394.
25. Merten OW (2002) Development of serum-free media for cell growth and production of viruses/viral vaccines-safety issues of animal products used in serum-free media. Developments in Biological Standardization 111: 233-257.
26. Zhang S, Handa-Corrigan A, Spier RE (1992) Foaming and media surfactant effects on the cultivation of animal cells in stirred and sparged bioreactors. Journal of Biotechnology 25: 289-306.
27. Wu SC, Liu CC, Lian WC (2004) Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine 22: 3858-3864.
28. Genzel Y, Reichl U (2009) Continuous cell lines as a production system for influenza vaccines. Expert Review of Vaccines 8: 1681-1692.
29. World Health Organisations (2002) WHO manual on animal influenza diagnosis and surveillance. Geneva.